Skip to main content

Table 3 In vitro antifungal susceptibility pattern of the isolates (n = 87)

From: Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

Species Antifungal agent MIC range (μg/ml) % susceptible of the isolates % intermediate of the isolates % resistant of the isolates
C. albicans (51) Fluconazole ≤ 1 98.0 2.0 0
Voriconazole ≤ 0.12 100 0 0
Caspofungin ≤ 0.25–0.5 100 0 0
Micafungin ≤ 0.06 - ≤ 0.25 100 0 0
Flycytosine ≤ 1 98.0 2.0 0
C. krusei (15) Fluconazole 2 - ≥ 64 0 0 100
Voriconazole ≤ 0.12 - ≤ 0.25 100 0 0
Caspofungin ≤ 0.25–0.5 100 0 0
Micafungin ≤0.12 - ≤ 0.25 100 0 0
Flycytosine ≤0.25–16 66.7 0 33.3
C. dubliniesis (8) Fluconazole ≤1–32 87.5 12.5 0
Voriconazole ≤0.12 100 0 0
Caspofungin ≤0.25 100 0 0
Micafungin ≤ − 0.06–0.12 100 0 0
Flycytosine ≤1–8 87.5 12.5 0
C. glabrata (3) Fluconazole 4 100 0 0
Voriconazole ≤0–1 2 100 0 0
Caspofungin ≤0.25 100 0 0
Micafungin ≤0.06 100 0 0
Flycytosine ≤1 100 0 0
C. tropicalis (2) Fluconazole ≤1 100 0 0
Voriconazole ≤0.12 100 0 0
Caspofungin ≤0.25 100 0 0
Micafungin ≤0.06 100 0 0
Flycytosine ≤1 100 0 0
C. kefyr (2) Fluconazole ≤1 100 0 0
Voriconazole ≤0.12 100 0 0
Caspofungin ≤0.25 100 0 0
Micafungin 0.12 100 0 0
Flycytosine ≤1 100 0 0
C. guillieromondii (2) Fluconazole 2 100 0 0
Voriconazole ≤0.12 100 0 0
Caspofungin ≤0.5 100 0 0
Micafungin 0..5 100 0 0
Flycytosine ≤1 100 0 0
C. parapsilosis (2) Fluconazole ≤1 100 0 0
Voriconazole ≤0.12 100 0 0
Caspofungin ≤0.25 100 0 0
Micafungin ≤0.25 100 0 0
Flycytosine ≤1 100 0 0
C. lusitaniae (1) Fluconazole 2 100 0 0
Voriconazole ≤0.12 100 0 0
Caspofungin ≤ 0.25 100 0 0
Micafungin 0.5 100 0 0
Flycytosine ≤1 100 0 0
C. inconspicua (1) Fluconazole ≤1 100 0 0
Voriconazole ≤0.12 100 0 0
Caspofungin ≤0.25 100 0 0
Micafungin ≤0.06 100 0 0
Flycytosine ≤1 100 0 0